# AEON Biopharma, Inc. (AEON)

> Source: Nexqual · https://nexqual.com/AEON · data as of 2026-10-15 19:59 UTC · cite as "Nexqual, AEON Biopharma, Inc. (AEON), nexqual.com/AEON" · informational, not investment advice.

**Price:** USD 0.24 (+6.16% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 0.23 · day 0.23–0.25 · 52w 0.18–1.45 · market cap $12.1M · ASE

## Key facts
- Total return with dividends: 1Y -82.6% vs S&P 500 +18.1%; 5Y -100.0% vs S&P 500 +85.1%.

## Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters)
| USD | FY2021 | FY2022 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|
| Operating income | -$1.9M | -$48.4M | $73.0M | -$12.8M | -$19.9M |
| Net income | $8.2M | -$52.6M | $42.0M | -$39.2M | -$54.6M |
| EPS (diluted) | — | -$27.36 | $72.93 | -$3.95 | — |
| Free cash flow | — | -$35.9M | — | -$17.3M | — |
| Cash + short-term investments | $497K | $9.7M | $13K | $3.0M | — |
Fiscal years end Dec. EPS is split-adjusted.

## Valuation (price ÷ last four quarters, through Jun 30, 2026)
Earnings yield -450.63%
P/E at fiscal year-ends: Dec 2024 0.5x.

## Analysts
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-01 | Lake Street | Target raised | Buy | $1 → $2 |
| 2026-08-14 | HC Wainwright & Co. | Target lowered | Buy | $5 → $1.2 |
| 2026-07-30 | Lake Street | Initiated | Buy | $1 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2023-01-02) |
|---|---|---|
| Total return | -82.6% | -100.0% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -82.8% | -87.9% |
| Volatility (annualized) | 110.6% | 191.1% |
| Max drawdown | -86.3% (Oct 2025→Aug 2026) | -100.0% (Mar 2024→Aug 2026) |

## Peers (Biotechnology)
RYTM (Rhythm Pharmaceuticals, Inc.) USD 87.97 +1.57% · BLTE (Belite Bio, Inc) USD 152.62 +0.49% · IOVA (Iovance Biotherapeutics, Inc.) USD 14.72 +1.52% · PRAX (Praxis Precision Medicines, Inc) USD 248.24 +2.01% · IONS (Ionis Pharmaceuticals, Inc.) USD 44.12 +4.11% · SYRE (Spyre Therapeutics, Inc.) USD 80.1 -0.44%

## More
Full page: https://nexqual.com/AEON · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt